Protagen: Protagen and German National Center for Tumor Diseases, Heidelberg, to Investigate Immunocompetence of Cancer Patients

Protagen has extended its collaboration with the National Center for Tumor Diseases, Heidelberg, to investigate the immunocompetence of urothelial cancer patients receiving immunotherapy.